Skip to content

Clinical trials

Phase 1 Hepatitis B trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1 Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20123
20153
20161
20171
20183
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dong-A ST Co., Ltd.2
Gilead Sciences2
Alios Biopharma Inc.1
Alnylam Pharmaceuticals1
Altimmune, Inc.1
Aribio Lab Co., Ltd.1
Assembly Biosciences1
Genexine, Inc.1
GigaGen, Inc.1
Green Cross Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B17
Hepatitis B, Chronic6
Hepatitis3
Chronic Disease1
DNA Virus Infections1
Diphtheria1
Haemophilus Infections1
Hepatitis, Chronic1
Poliomyelitis1
Tetanus1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.